文献速递儿科与产科急症复苏、休克与脓毒症

预防性应用复苏性主动脉腔内球囊阻断术用于胎盘异常植入孕妇:系统评价、Meta分析与病例系列

Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: A systematic review, meta-analysis, and case series.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论病例系列显示MAP孕妇择期剖宫产预防性REBOA可行,Meta分析示REBOA与术中出血量及输血需求降低相关。

本文报道了2015年12月至2017年6月期间12例胎盘异常植入(MAP)孕妇在择期剖宫产术中预防性放置REBOA的病例系列,术后24小时输注浓缩红细胞中位数为2单位(四分位距0-3.5),术中出血量中位数为1500 mL(四分位距900-2750),28天时全部存活且未观察到不良结局。同时按照PRISMA指南进行系统评价和Meta分析,纳入4篇文章共441例患者,定量合成发现预防性REBOA与术中出血量(mL)减少(加权均数差-1384.66,95%CI -2141.74至-627.58)及血制品输注需求(单位)降低(加权均数差-2.42,95%CI -3.90至-0.94)相关。结论认为REBOA作为预防性干预用于有灾难性产后出血风险的MAP孕妇具有可行性。证据等级:治疗性研究V级;系统评价IV级。

要点

  • 12例MAP孕妇择期剖宫产预防性REBOA,术后24小时输注浓缩红细胞中位数2单位(IQR 0-3.5),术中出血量中位数1500 mL(IQR 900-2750)。
  • 病例系列中28天时全部患者存活,未观察到不良结局。
  • Meta分析纳入4篇文献共441例,预防性REBOA与术中出血量减少相关(加权均数差-1384.66 mL,95%CI -2141.74至-627.58)。
  • Meta分析示预防性REBOA与血制品输注需求降低相关(加权均数差-2.42单位,95%CI -3.90至-0.94)。
  • 证据等级为治疗性研究V级、系统评价IV级。

适用人群与场景

  • 诊断为胎盘异常植入(MAP)并接受择期剖宫产的孕妇。
  • 病例系列为2015年12月至2017年6月期间接受预防性REBOA的MAP孕妇。
  • 系统评价纳入诊断为MAP并接受择期剖宫产、预防性放置REBOA的研究。

处置流程与药物剂量

  • 对MAP孕妇在择期剖宫产术中预防性放置REBOA球囊。

研究设计与关键结果

  • 病例系列:12例MAP孕妇择期剖宫产术中放置REBOA,术后24小时输注浓缩红细胞中位数2单位(IQR 0-3.5),术中出血量中位数1500 mL(IQR 900-2750),28天全部存活且未观察到不良结局。
  • 系统评价与Meta分析纳入4篇文章共441例患者,预防性REBOA与术中出血量(mL)减少相关(加权均数差-1384.66,95%CI -2141.74至-627.58)。
  • Meta分析示预防性REBOA与血制品输注需求(单位)降低相关(加权均数差-2.42,95%CI -3.90至-0.94)。

证据类型、等级与局限

  • 证据类型:病例系列(描述性)、系统评价与Meta分析。
  • 证据等级:治疗性研究V级;系统评价IV级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为REBOA可作为预防性干预用于有灾难性产后出血风险的MAP孕妇以改善结局,并认为其在该人群择期剖宫产中具有可行性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We describe intraoperative and postdischarge outcomes of a case series after the prophylactic use of resuscitative endovascular balloon occlusion of the aorta (REBOA) during elective cesarean delivery in pregnant women with morbidly adherent placenta (MAP). We furthermore performed a systematic review and meta-analysis to investigate the safety and effectiveness of the use of REBOA during elective cesarean delivery in pregnant women with MAP.

METHODS: Descriptive case series of REBOA (December 2015 to June 2017) used during elective cesarean delivery in pregnant women with MAP. The systematic review was conducted following PRISMA guidelines. We included studies involving pregnant women with a diagnosis of MAP who underwent an elective cesarean delivery with prophylactic REBOA placement. A meta-analysis was performed to assess the overall amount of transfusions and intraoperative hemorrhage of REBOA compared to NO-REBOA cases.

RESULTS: A total of 12 patients with MAP underwent elective cesarean delivery with REBOA deployment. The median (interquartile range) of packed red blood cells transfused during the first 24 hours following surgery was two units (0-3.5). The median (interquartile range) of intraoperative blood loss was 1,500 mL (900-2,750). At 28 days, all patients were alive, and no adverse outcomes were observed. Four articles were included in the systematic review and meta-analysis. These articles included a total of 441 patients. Quantitative synthesis (meta-analysis) found that the use of REBOA as prophylaxis for the prevention of major hemorrhage was associated with a lower amount of intraoperative hemorrhage (in milliliters) (weighted mean difference, -1,384.66; 95% confidence interval, -2,141.74 to -627.58) and lower requirements of blood products transfusions (in units) (weighted mean difference, -2.42; 95% confidence interval, -3.90 to -0.94).

CONCLUSION: We provide clinical data supporting the use of REBOA in the management of pregnant women with MAP undergoing elective cesarean delivery. Our findings demonstrate the feasibility of REBOA as a prophylactic intervention to improve outcomes in women at risk of catastrophic postpartum hemorrhage.

LEVEL OF EVIDENCE: Therapeutic study, level V; Systematic Review, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Ordoñez CA, Manzano-Nunez R, Parra MW, et al. Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: A systematic review, meta-analysis, and case series. J Trauma Acute Care Surg. 2018. PMID: 29401189. doi:10.1097/TA.0000000000001821

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。